[ad_1] Boehringer Ingelheim and Eli Lilly announced on June 28 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) On the basis of additional data …
Read More »[메디파나뉴스] CV and kidney of European CHMP "Zadien" benefit from "positive opinion"
